Sesame to offer Wegovy compound through weight loss program
Healthcare marketplace Sesame announced Wednesday a new clinical weight loss program that will help eligible consumers access compounded versions of…
Novo Nordisk A/S
Eli Lilly weight-loss drug reduces diabetes risk in trial
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
What's next in Biden's Medicare drug price negotiations?
U.S. President Joe Biden and Vice President Kamala Harris walk together at an event on Medicare drug pricing negotiations in…
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Weight loss drugs from Eli Lilly and Novo Nordisk
A Zepbound injection pen from Eli Lilly & Co., March 28, 2024. Bloomberg | Bloomberg | Getty Images Do you…
Ro launches GLP-1 insurance coverage checker
Zoom iconArrows pointing outwards Direct-to-consumer healthcare startup Ro on Tuesday launched a new, free tool to help patients determine whether…
What Wall Street is watching
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
FDA says Eli Lilly's Zepbound and Mounjaro are available after shortage
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City, Dec. 11, 2023. Brendan McDermid…
Eli Lilly's Zepbound weight-loss drug cuts heart failure risks, study finds
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
GLP-1s are being tested for uses beyond weight loss and diabetes
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…